Pharmacokinetics and Safety of Lefamulin After Single Intravenous Dose Administration in Subjects with Impaired Renal Function and those Requiring Hemodialysis

2021 ◽  
Author(s):  
Wolfgang W. Wicha ◽  
Thomas C. Marbury ◽  
James A. Dowell ◽  
Jared L. Crandon ◽  
Cathie Leister ◽  
...  
Keyword(s):  
Renal Function ◽  
Impaired Renal Function ◽  
Intravenous Dose ◽  
Single Intravenous Dose ◽  
Dose Administration

scholarly journals Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.

1996 ◽  
Vol 40 (8) ◽  
pp. 1806-1810 ◽  
Author(s):  
K M Wasan ◽  
J S Conklin
Keyword(s):  
Renal Function ◽  
Antifungal Activity ◽  
Amphotericin B ◽  
Fungal Infections ◽  
Diabetic Rats ◽  
Intravenous Dose ◽  
Diabetic Patients ◽  
Systemic Candidiasis ◽  
Single Intravenous Dose ◽  
The Right

Since fungal infections are prevalent in diabetic patients, in whom treatment is often complicated by underlying renal disease and dyslipidemias, the purpose of the present study was to determine if the antifungal activity and nephrotoxic effects of amphotericin B (AmB) and liposomal AmB (L-AmB) are different in nondiabetic (normolipidemic) rats compared with those in diabetic (dyslipidemic) rats with systemic candidiasis. Non diabetic and diabetic rats infected with Candida albicans received a single intravenous dose of either AmB (0.8 mg of AmB per kg of body weight), L-AmB (0.8, 2, or 4 mg of AmB per kg), or an equivalent volume of normal saline (1 ml). Renal function was assessed by insulin clearance, and antifungal activity was determined by measuring the numbers of CFU of C. albicans that were present in the right kidney following drug treatment. AmB at 0.8 mg/kg and L-AmB at 0.8, 2, and 4 mg/kg are effective antifungal agents in both diabetic and nondiabetic rats. However, while there was approximately a 4-fold decline in the mean number of CFU per gram of kidney in nondiabetic rats, there was only approximately a 2.5-fold decline for the comparable dose (AmB, 0.8 mg/kg) in diabetic rats. There also appeared to be a similar fold reduction of L-AmB at all of the dosages tested. AmB treatment significantly improved renal function in diabetic and nondiabetic rats with systemic candidiasis. Although L-AmB at all doses tested significantly improved renal function in diabetic rats with systemic candidiasis, only L-AmB at doses of 2 and 4 mg/kg significantly improved renal function in nondiabetic rats with systemic candidiasis. These findings suggest that following administration of a single intravenous dose, AmB and L-AmB appear to be less effective in killing C. albicans isolates in diabetic than in nondiabetic rats, while they were found to improve the renal functions of rats in both treatment groups.

scholarly journals The pharmacokinetics of peginterferon lambda-1a following single dose administration to subjects with impaired renal function

2015 ◽  
Vol 80 (3) ◽  
pp. 515-524 ◽  
Author(s):  
Matthew W. Hruska ◽  
Robert Adamczyk ◽  
Elizabeth Colston ◽  
Michael Hesney ◽  
Michele Stonier ◽  
...  
Keyword(s):  
Renal Function ◽  
Single Dose ◽  
Impaired Renal Function ◽  
Dose Administration ◽  
Single Dose Administration

Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function

Infection ◽  
1980 ◽  
Vol 8 (S3) ◽  
pp. S305-S309 ◽  
Author(s):  
O. S. Nielsen ◽  
R. W. Bundtzen ◽  
W. A. Craig ◽  
P. O. Madsen ◽  
R. D. Toothaker ◽  
...  
Keyword(s):  
Renal Function ◽  
Intravenous Dose ◽  
Single Intravenous Dose

Penetration of Imipenem into Human Pancreatic Juice following Single Intravenous Dose Administration1

Chemotherapy ◽  
1989 ◽  
Vol 35 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Christina Brattström ◽  
Anna-Stina Malmborg ◽  
Gunnar Tydén
Keyword(s):  
Pancreatic Juice ◽  
Intravenous Dose ◽  
Single Intravenous Dose ◽  
Dose Administration
Sign in / Sign up

Export Citation Format

Share Document